#randomized controlled trial

1 article

A wide, minimalist editorial still life on a soft, warm-gray linen surface lit by gentle diffused morning window light. At center sit two identical small amber glass supplement bottles, one slightly in front of the other, with plain matte cream labels and no readable text. In front of them, two matching shallow ceramic dishes in muted sage green hold identical small ivory capsules. The capsules are nearly indistinguishable, which quietly suggests placebo versus active. Beside the dishes, a few wheat germ grains, a small cluster of aged cheddar-toned cheese shards, and a halved ripe mushroom hint at natural spermidine food sources. They are arranged with careful negative space.

On the left, a delicate balance scale in brushed brass sits perfectly level, its two small pans empty and even, as a subtle visual metaphor for "no difference." On the right, a neat open notebook with soft blurred pencil lines and a single sprig of dried eucalyptus lies beside a pair of thin round tortoiseshell reading glasses, suggesting older adults and memory without showing any people.

The background is a softly blurred pale oat-colored wall with a long gentle shadow cast diagonally across the scene from a window. The color palette is muted and modern: warm cream, sage green, amber, soft brass, and dusty terracotta accents. Shallow depth of field keeps the bottles and scale crisp while the edges melt into a creamy blur. The mood is calm, thoughtful, and quietly skeptical, like a trendy health and science journal feature. Fine film grain, a subtle matte finish, and a balanced asymmetrical composition leave open space in the upper right for headline overlay. Photographed from a slightly elevated three-quarter angle, high-end editorial photography style.

Spermidină pentru memorie? Un studiu de 12 luni pe 100 de adulţi în vârstă nu a demonstrat niciun avantaj faţă de placebo

BY DR. SYNAPSE · 15 oct. 2026

Spermidina a fost promovată ca un supliment protector al creierului, bazându‑se pe cercetările despre autofagie și pe studiile pe animale. Studiul SmartAge a testat această ipoteză pe 100 de persoane în vârstă cu declin cognitiv subiectiv, administrând aproximativ 0,9 mg pe zi timp de 12 luni. Rezultatul principal legat de memorie nu a depășit placebo (diferență -0,03; P = 0,47), iar rezultatele secundare au fost nule. Indiciile exploratorii privind inflamaţia şi memoria verbală rămân neconfirmate. Iată ce înseamnă aceste rezultate pentru cei care se gândesc să ia un supliment cu spermidină și care sunt limitările studiului.